Sheila Gujrathi, MD

Sheila Gujrathi, MD has a long and distinguished career in the medical field. Sheila is currently a Venture Advisor for OrbiMed (2021), Executive Chair of the Board of Directors for Ventyx Biosciences (2021), Chair of the Board of Directors for IMMPACT BIO (2021), Chair of the Board of Directors for ADARx Pharmaceuticals Inc. (2020), Director Board of Directors for Janux Therapeutics (2021), Chair of the Board of Directors for Turning Point Therapeutics (2017), Board Member for Biotechnology Innovation Organization (2019), Co-Founder and Chief Executive Officer for Gossamer Bio (2016), Director Board of Directors for Five Prime Therapeutics, Inc. (2015), and Director Board of Directors for Ambrx (2014).

Sheila Gujrathi, MD completed their undergraduate studies at Northwestern University, where they earned a B.S. with Highest Distinction through the Seven Year Honors Program in Medical Education in the field of Biomedical Engineering. Sheila then went on to Northwestern University - The Feinberg School of Medicine, where they completed their M.D. through the same program.